Retirement Systems of Alabama
ALXN

Retirement Systems of Alabama’s Alexion Pharmaceuticals ALXN Stock Holding History

Retirement Systems of Alabama’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-80,849
Closed -$14.9M – 935
2021
Q2 		$14.9M Sell
80,849
-1,152
-1% -$198K 0.05% 374
2021
Q1 		$12.5M Sell
82,001
-189,825
-70% -$29.4M 0.05% 426
2020
Q4 		$42.5M Sell
271,826
-311
-0.1% -$40K 0.17% 118
2020
Q3 		$31.1M Buy
272,137
+16,418
+6% +$1.77M 0.14% 138
2020
Q2 		$28.7M Buy
255,719
+158,442
+163% +$16.8M 0.14% 146
2020
Q1 		$8.73M Buy
97,277
+23
+0% +$2.26K 0.05% 370
2019
Q4 		$10.5M Sell
97,254
-938
-1% -$100K 0.05% 424
2019
Q3 		$9.62M Sell
98,192
-6,380
-6% -$719K 0.05% 436
2019
Q2 		$13.7M Buy
104,572
+516
+0.5% +$66.5K 0.06% 323
2019
Q1 		$14.1M Buy
104,056
+1,282
+1% +$159K 0.07% 297
2018
Q4 		$10M Hold
102,774
– – 0.06% 366
2018
Q3 		$14.3M Sell
102,774
-1,739
-2% -$218K 0.07% 311
2018
Q2 		$13M Sell
104,513
-1,387
-1% -$162K 0.06% 343
2018
Q1 		$11.8M Sell
105,900
-62,466
-37% -$7.47M 0.06% 371
2017
Q4 		$20.1M Sell
168,366
-14
-0% -$1.71K 0.1% 208
2017
Q3 		$23.6M Sell
168,380
-599
-0.4% -$81.4K 0.12% 156
2017
Q2 		$20.6M Buy
168,979
+304
+0.2% +$35.4K 0.11% 186
2017
Q1 		$20.4M Sell
168,675
-821
-0.5% -$106K 0.11% 180
2016
Q4 		$20.7M Sell
169,496
-4,023
-2% -$492K 0.12% 180
2016
Q3 		$21.3M Sell
173,519
-79,589
-31% -$10.2M 0.12% 170
2016
Q2 		$29.6M Buy
253,108
+1,947
+0.8% +$276K 0.17% 114
2016
Q1 		$35M Sell
251,161
-4,588
-2% -$674K 0.21% 97
2015
Q4 		$48.8M Buy
255,749
+32,166
+14% +$5.62M 0.29% 67
2015
Q3 		$35M Sell
223,583
-13,958
-6% -$2.55M 0.21% 99
2015
Q2 		$42.9M Buy
237,541
+108,838
+85% +$18.8M 0.23% 90
2015
Q1 		$22.3M Buy
128,703
+8,132
+7% +$1.47M 0.12% 183
2014
Q4 		$22.3M Sell
120,571
-192
-0.2% -$35.6K 0.12% 186
2014
Q3 		$20M Sell
120,763
-3
-0% -$493 0.11% 198
2014
Q2 		$18.9M Buy
120,766
+1,845
+2% +$291K 0.11% 217
2014
Q1 		$18.1M Buy
118,921
+2,405
+2% +$382K 0.1% 214
2013
Q4 		$15.5M Buy
116,516
+131
+0.1% +$15.7K 0.09% 234
2013
Q3 		$13.5M Buy
116,385
+1,017
+0.9% +$112K 0.09% 254
2013
Q2 		$10.6M Buy
+115,368
New +$11.1M 0.07% 306

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Retirement Systems of Alabama's ALXN Position: Q3 2021 in Review

Retirement Systems of Alabama sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 80,849 shares — an estimated $14.9M sold.

Retirement Systems of Alabama first reported a position in ALXN in Q2 2013 and held it in 33 quarters. The position peaked at $48.8M in Q4 2015. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Retirement Systems of Alabama reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Retirement Systems of Alabama sold 80,849 Alexion Pharmaceuticals shares in Q3 2021, an estimated $14.9M.
  • Retirement Systems of Alabama first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 33 quarters.
  • Retirement Systems of Alabama's Alexion Pharmaceuticals position peaked at $48.8M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Retirement Systems of Alabama's 13F filing for Q3 2021, filed 3 Nov 2021.